{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:22:13Z","timestamp":1783527733958,"version":"3.55.0"},"reference-count":26,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Diabetic retinopathy (DR), a prevalent neurovascular complication of diabetes, is a leading cause of blindness in affected individuals. O-linked \u03b2-D-N-acetylglucosamine modification (O-GlcNAcylation), a unique form of post-translational modification regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase, plays a critical role in cellular processes. This study aimed to investigate the role of OGT-mediated O-GlcNAcylation and its potential regulatory mechanisms in DR. Using a DR mouse model, we evaluated the effect of OGT on retinal tissue damage. An in vitro model was established by treating human retinal endothelial cells (HRECs) with high glucose (HG). The biological behaviors of HRECs were assessed using Cell Counting Kit-8, EdU incorporation, transwell, and tube formation assays. Underlying mechanisms were explored through quantitative real-time PCR, western blot, and co-immunoprecipitation. Our findings revealed that O-GlcNAcylation levels were significantly elevated both in vitro and in vivo. Knockdown of OGT suppressed the proliferation, migration, and angiogenesis of HG-stimulated HRECs, an effect mediated through the upregulation of BAP1. Mechanistically, OGT was found to interact with BAP1 and promote its O-GlcNAcylation, thereby negatively regulating BAP1 expression. Furthermore, OGT knockdown attenuated retinal tissue damage in diabetic mice, an effect dependent on BAP1. In summary, this study reveals a novel role for OGT-mediated O-GlcNAcylation in DR progression, suggesting its potential as a therapeutic target for DR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/jme-25-0065","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:24:02Z","timestamp":1778577842000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":0,"title":["OGT accelerates diabetic retinopathy via\n                    <i>O<\/i>\n                    -GlcNAcylation of BAP1"],"prefix":"10.1530","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8514-1295","authenticated-orcid":true,"given":"Bairong","family":"Wang","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junteng","family":"Yao","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuren","family":"Zhang","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Li","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinting","family":"Xu","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Chen","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolan","family":"Liu","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Li","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026070811524893200_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-021-01289-4","article-title":"Variability of risk factors and diabetes complications","volume":"20","author":"Ceriello","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2026070811524893200_bib3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1161\/ATVBAHA.119.312192","article-title":"Metabolic stress and cardiovascular disease in diabetes mellitus: the role of protein O-GlcNAc modification","volume":"39","author":"Chen","year":"2019","journal-title":"Arterioscl Throm Vas"},{"key":"2026070811524893200_bib4","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1074\/jbc.RA119.007494","article-title":"O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1-dependent mitochondrial dysfunction in the retina","volume":"294","author":"Dierschke","year":"2019","journal-title":"J Biol Chem"},{"key":"2026070811524893200_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2478\/s11658-014-0204-6","article-title":"The potential role of O-GlcNAc modification in cancer epigenetics","volume":"19","author":"Forma","year":"2014","journal-title":"Cell Mol Biol Lett"},{"key":"2026070811524893200_bib6","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr Protoc"},{"key":"2026070811524893200_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dme.12089","article-title":"Diabetic retinopathy: pathogenesis, clinical grading, management and future developments","volume":"30","author":"Heng","year":"2013","journal-title":"Diabetic Med"},{"key":"2026070811524893200_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2010.09.001","article-title":"O-GlcNAc modification, insulin signaling and diabetic complications","volume":"36","author":"Issad","year":"2010","journal-title":"Diabetes Metab"},{"key":"2026070811524893200_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"2026070811524893200_bib10","first-page":"1203","article-title":"Aralia elata inhibits neurodegeneration by downregulating O-GlcNAcylation of NF-kappaB in diabetic mice","volume":"10","author":"Kim","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"2026070811524893200_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/02713683.2015.1006372","article-title":"Increased O-GlcNAcylation of NF-kappaB enhances retinal ganglion cell death in streptozotocin-induced diabetic retinopathy","volume":"41","author":"Kim","year":"2016","journal-title":"Curr Eye Res"},{"key":"2026070811524893200_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema","volume":"102","author":"Klein","year":"1995","journal-title":"Ophthalmology"},{"key":"2026070811524893200_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s12276-023-00979-1","article-title":"BAP1 as a guardian of genome stability: implications in human cancer","volume":"55","author":"Kwon","year":"2023","journal-title":"Exp Mol Med"},{"key":"2026070811524893200_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47246-w","article-title":"GRP78 translocation to the cell surface and O-GlcNAcylation of VE-Cadherin contribute to ER stress-mediated endothelial permeability","volume":"9","author":"Lenin","year":"2019","journal-title":"Sci Rep"},{"key":"2026070811524893200_bib15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/ijmm.2015.2319","article-title":"The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells","volume":"36","author":"Liu","year":"2015","journal-title":"Int J Mol Med"},{"key":"2026070811524893200_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1167\/iovs.14-15220","article-title":"Metanx and early stages of diabetic retinopathy","volume":"56","author":"Liu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026070811524893200_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035285","article-title":"Vascular complications of diabetes: a narrative review","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine"},{"key":"2026070811524893200_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Differ"},{"key":"2026070811524893200_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2017.08.029","article-title":"Suppressive role of OGT-mediated O-GlcNAcylation of BAP1 in retinoic acid signaling","volume":"492","author":"Moon","year":"2017","journal-title":"Biochem Bioph Res Co"},{"key":"2026070811524893200_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1631\/jzus.B1900150","article-title":"O-GlcNAcylation, a sweet link to the pathology of diseases","volume":"20","author":"Nie","year":"2019","journal-title":"J Zhejiang Univ Sci B"},{"key":"2026070811524893200_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/10409238.2015.1135102","article-title":"New insights: a role for O-GlcNAcylation in diabetic complications","volume":"51","author":"Peterson","year":"2016","journal-title":"Crit Rev Biochem Mol"},{"key":"2026070811524893200_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116374","article-title":"PLK-3-mediated phosphorylation of BAP1 prevents diabetic retinopathy","volume":"226","author":"Qin","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"2026070811524893200_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.114.303684","article-title":"Modifying vascular calcification in diabetes mellitus: contribution of O-GlcNAcylation","volume":"114","author":"Rogers","year":"2014","journal-title":"Circ Res"},{"key":"2026070811524893200_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cmet.2012.07.006","article-title":"O-GlcNAc transferase\/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability","volume":"16","author":"Ruan","year":"2012","journal-title":"Cell Metab"},{"key":"2026070811524893200_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pr"},{"key":"2026070811524893200_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28892-y","article-title":"O-GlcNAcylation of FoxO1 mediates nucleoside diphosphate kinase B deficiency induced endothelial damage","volume":"8","author":"Shan","year":"2018","journal-title":"Sci Rep"},{"key":"2026070811524893200_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.456","article-title":"O-GlcNAcylation: cellular physiology and therapeutic target for human diseases","volume":"4","author":"Ye","year":"2023","journal-title":"MedComm"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jme.bioscientifica.com\/view\/journals\/jme\/76\/4\/JME-25-0065.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jme.bioscientifica.com\/downloadpdf\/journals\/jme\/76\/4\/JME-25-0065.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/doi\/10.1530\/JME-25-0065\/520270\/jme-25-0065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/doi\/10.1530\/JME-25-0065\/520270\/jme-25-0065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:52:55Z","timestamp":1783525975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article\/76\/4\/e250065\/77625\/OGT-accelerates-diabetic-retinopathy-via-O"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/jme-25-0065","relation":{},"ISSN":["1479-6813","0952-5041"],"issn-type":[{"value":"1479-6813","type":"electronic"},{"value":"0952-5041","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"e250065"}}